{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:34:32Z","timestamp":1777030472288,"version":"3.51.4"},"reference-count":30,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multifocal papillary thyroid cancer (PTC) can arise from independent primaries with discordant drivers in parallel clonal evolution rather than a single-clone pattern. We present a 31-year-old female with multifocal PTC harboring 3 distinct oncogenic alterations: a germline RET p.V804M mutation, low-frequency EML4-ALK fusion, and BRAF V600E mutation. The RET and ALK alterations were identified in a midpole nodule, whereas BRAF positivity was seen in a separate lower pole tumor. Ultrasound revealed multiple right-lobe thyroid nodules; the dominant 2.1-cm lesion was hypoechoic with calcifications. Fine needle aspiration revealed Bethesda III cytology, prompting thyroid lobectomy and an ipsilateral central neck dissection was performed. Histopathology confirmed multifocal PTC and a background of chronic lymphocytic thyroiditis with 23 lymph nodes negative for metastasis. This case presents heterogeneity of oncogenic drivers in PTC and the potential value of comprehensive molecular profiling in risk stratification and management.<\/jats:p>","DOI":"10.1210\/jcemcr\/luag072","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:40:01Z","timestamp":1772109601000},"source":"Crossref","is-referenced-by-count":0,"title":["Multifocal papillary thyroid carcinoma with\n                    <i>RET p.V804M<\/i>\n                    ,\n                    <i>EML4-ALK<\/i>\n                    fusion, and\n                    <i>BRAF V600E<\/i>\n                    positivity"],"prefix":"10.1210","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8552-787X","authenticated-orcid":false,"given":"Jacob","family":"Beiriger","sequence":"first","affiliation":[{"name":"Sidney Kimmel Medical College , Philadelphia, PA 19107 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard E","family":"Estephan","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2014Head and Neck Surgery, Thomas Jefferson University Hospitals , Philadelphia, PA 19107 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubna","family":"Zuberi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolic Diseases, Department of Medicine, Thomas Jefferson University Hospitals , Philadelphia, PA 19107 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Gargano","sequence":"additional","affiliation":[{"name":"Department of Pathology and Genomic Medicine, Thomas Jefferson University Hospitals , Philadelphia, PA 19107 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5861-5428","authenticated-orcid":false,"given":"Elizabeth","family":"Cottrill","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2014Head and Neck Surgery, Thomas Jefferson University Hospitals , Philadelphia, PA 19107 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"3","key":"2026042406351720000_luag072-B1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.7150\/ijms.29935","article-title":"Papillary thyroid cancer: genetic alterations and molecular biomarker investigations","volume":"16","author":"Abdullah","year":"2019","journal-title":"Int J Med Sci"},{"issue":"5","key":"2026042406351720000_luag072-B2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: a review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"issue":"5","key":"2026042406351720000_luag072-B3","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ijc.28976","article-title":"Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma","volume":"137","author":"Gandolfi","year":"2015","journal-title":"Int J Cancer"},{"issue":"11","key":"2026042406351720000_luag072-B4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMra1501993","article-title":"Biologic and clinical perspectives on thyroid cancer","volume":"375","author":"Fagin","year":"2016","journal-title":"N Engl J Med"},{"issue":"14","key":"2026042406351720000_luag072-B5","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.2013.3190","article-title":"Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer","volume":"309","author":"Xing","year":"2013","journal-title":"JAMA"},{"issue":"9","key":"2026042406351720000_luag072-B6","doi-asserted-by":"crossref","first-page":"100242","DOI":"10.1016\/j.modpat.2023.100242","article-title":"A shift in molecular drivers of papillary thyroid carcinoma following the 2017 World Health Organization classification: characterization of 554 consecutive tumors with emphasis on BRAF-negative cases","volume":"36","author":"Hang","year":"2023","journal-title":"Mod Pathol"},{"issue":"8","key":"2026042406351720000_luag072-B7","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaoncol.2023.1379","article-title":"Diagnosis and management of tropomyosin receptor kinase fusion-positive thyroid carcinomas: a review","volume":"9","author":"Haddad","year":"2023","journal-title":"JAMA Oncol"},{"issue":"12","key":"2026042406351720000_luag072-B8","doi-asserted-by":"crossref","first-page":"100329","DOI":"10.1016\/j.modpat.2023.100329","article-title":"A detailed histologic and molecular assessment of the diffuse sclerosing variant of papillary thyroid carcinoma","volume":"36","author":"Chou","year":"2023","journal-title":"Mod Pathol"},{"issue":"11","key":"2026042406351720000_luag072-B9","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/PAS.0000000000002256","article-title":"Multifocal papillary thyroid carcinomas with discordant molecular drivers: emphasizing the morphology and collision tumors","volume":"48","author":"Rivera","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2026042406351720000_luag072-B10","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3390\/cancers11101516","article-title":"Epidemiology of simultaneous medullary and papillary thyroid carcinomas (MTC\/PTC): an Italian multicenter study","volume":"11","author":"Appetecchia","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2026042406351720000_luag072-B11","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.surg.2010.09.004","article-title":"Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary\/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation","volume":"148","author":"Shifrin","year":"2010","journal-title":"Surgery"},{"issue":"4","key":"2026042406351720000_luag072-B12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrendo.2016.11","article-title":"A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma","volume":"12","author":"Romei","year":"2016","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"2026042406351720000_luag072-B13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41574-021-00470-9","article-title":"The importance of the RET gene in thyroid cancer and therapeutic implications","volume":"17","author":"Salvatore","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"2026042406351720000_luag072-B14","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa2005651","article-title":"Efficacy of selpercatinib in RET-altered thyroid cancers","volume":"383","author":"Wirth","year":"2020","journal-title":"N Engl J Med"},{"issue":"13","key":"2026042406351720000_luag072-B15","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/cncr.29044","article-title":"The RET oncogene in papillary thyroid carcinoma","volume":"121","author":"Prescott","year":"2015","journal-title":"Cancer"},{"issue":"2","key":"2026042406351720000_luag072-B16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0002-9440(10)63316-0","article-title":"The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma","volume":"165","author":"Melillo","year":"2004","journal-title":"Am J Pathol"},{"issue":"5","key":"2026042406351720000_luag072-B17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/PAS.0000000000000368","article-title":"A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma","volume":"39","author":"Chou","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"2026042406351720000_luag072-B18","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/s41379-020-0638-5","article-title":"Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization","volume":"33","author":"Chu","year":"2020","journal-title":"Mod Pathol"},{"issue":"11","key":"2026042406351720000_luag072-B19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1530\/ERC-19-0325","article-title":"Characterization of thyroid cancer driven by known and novel ALK fusions","volume":"26","author":"Panebianco","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2026042406351720000_luag072-B20","doi-asserted-by":"crossref","first-page":"e87170","DOI":"10.1371\/journal.pone.0087170","article-title":"Identification of a recurrent STRN\/ALK fusion in thyroid carcinomas","volume":"9","author":"P\u00e9rot","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"2026042406351720000_luag072-B21","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1530\/JOE-17-0266","article-title":"Key signaling pathways in thyroid cancer","volume":"235","author":"Zaballos","year":"2017","journal-title":"J Endocrinol"},{"issue":"2","key":"2026042406351720000_luag072-B22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cen.15251","article-title":"Multigene detection analysis of multifocal papillary thyroid carcinoma","volume":"103","author":"Fang","year":"2025","journal-title":"Clin Endocrinol"},{"issue":"10","key":"2026042406351720000_luag072-B23","doi-asserted-by":"crossref","first-page":"E275","DOI":"10.1002\/dc.25004","article-title":"Bilateral follicular variant of papillary thyroid cancer with different RAS mutations detected with next-generation sequencing: report of an unusual case and literature review","volume":"50","author":"Mar\u00edn","year":"2022","journal-title":"Diagn Cytopathol"},{"issue":"9","key":"2026042406351720000_luag072-B24","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1210\/jc.2007-0594","article-title":"The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma","volume":"92","author":"Giannini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026042406351720000_luag072-B25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jamasurg.2016.0825","article-title":"Molecular-directed treatment of differentiated thyroid cancer: advances in diagnosis and treatment","volume":"151","author":"Yip","year":"2016","journal-title":"JAMA Surg"},{"issue":"6","key":"2026042406351720000_luag072-B26","first-page":"751","article-title":"The BRAF(V600E) mutation analysis and risk stratification in papillary thyroid carcinoma","volume":"64","author":"Scheffel","year":"2021","journal-title":"Arch Endocrinol Metab"},{"issue":"24","key":"2026042406351720000_luag072-B27","doi-asserted-by":"crossref","first-page":"15626","DOI":"10.3390\/ijms232415626","article-title":"Association of BRAF(V600E) mutation with the aggressive behavior of papillary thyroid microcarcinoma: a meta-analysis of 33 studies","volume":"23","author":"Attia","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2026042406351720000_luag072-B28","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1210\/clinem\/dgae774","article-title":"Association of BRAF V600E allele frequency with clinicopathologic outcomes in papillary thyroid cancer","volume":"110","author":"Schumm","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026042406351720000_luag072-B29","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1200\/JCO.21.02767","article-title":"Somatic genomic testing in patients with metastatic or advanced cancer: ASCO provisional clinical opinion","volume":"40","author":"Chakravarty","year":"2022","journal-title":"J Clin Oncol"},{"issue":"8","key":"2026042406351720000_luag072-B30","doi-asserted-by":"crossref","first-page":"925","DOI":"10.6004\/jnccn.2022.0040","article-title":"Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Haddad","year":"2022","journal-title":"J Natl Compr Canc Netw"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/5\/luag072\/68147556\/luag072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/5\/luag072\/68147556\/luag072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:35:26Z","timestamp":1777026926000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luag072\/8661721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4,21]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luag072","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,21]]},"article-number":"luag072"}}